Literature DB >> 11390014

Characterization of the pharmacology, signal transduction and internalization of the fluorescent PACAP ligand, fluor-PACAP, on NIH/3T3 cells expressing PAC1.

P M Germano1, J Stalter, S V Le, M Wu, D J Yamaguchi, D Scott, J R Pisegna.   

Abstract

Fluor-PACAP, a fluorescent derivative of PACAP-27, has been confirmed to share a high affinity for PAC1 receptors transfected into NIH/3T3 cells and to have comparable pharmacological characteristics to the unconjugated, native form. Through competitive binding with 125I-PACAP-27, the two ligands exhibited similar dose- dependent inhibition. Additional examination of the efficacy of activating adenylyl cyclase revealed that both ligands analogously stimulated the production of cyclic AMP. Furthermore, PAC1 internalization visualized by our Fluor-PACAP, is compareable to that performed with the radioligand, 125I-PACAP-27, with maximal internalization achieved within thirty minutes. Thus, Fluor-PACAP exhibits intracellular signaling abilities homologous to the native ligand.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11390014      PMCID: PMC6707527          DOI: 10.1016/s0196-9781(01)00410-7

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  16 in total

1.  PACAP(6-38) is a PACAP receptor antagonist for breast cancer cells.

Authors:  J Leyton; Y Gozes; J Pisegna; D Coy; S Purdom; M Casibang; F Zia; T W Moody
Journal:  Breast Cancer Res Treat       Date:  1999-07       Impact factor: 4.872

Review 2.  Signaling mechanisms controlled by melanocortins in melanoma, lacrimal, and brain astroglial cells.

Authors:  Y Salomon; M Zohar; J O Dejordy; Y Eshel; I Shafir; H Leiba; N B Garty; J Schmidt-Sole; A Azrad; E Shai
Journal:  Ann N Y Acad Sci       Date:  1993-05-31       Impact factor: 5.691

3.  Localization and effects of pituitary adenylate cyclase-activating polypeptide (PACAP) in human penile erectile tissue.

Authors:  P Hedlund; P Alm; H Hedlund; B Larsson; K E Andersson
Journal:  Acta Physiol Scand       Date:  1994-01

4.  PACAP type I receptor activation regulates ECL cells and gastric acid secretion.

Authors:  N Zeng; C Athmann; T Kang; R M Lyu; J H Walsh; G V Ohning; G Sachs; J R Pisegna
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

5.  Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells.

Authors:  A Miyata; A Arimura; R R Dahl; N Minamino; A Uehara; L Jiang; M D Culler; D H Coy
Journal:  Biochem Biophys Res Commun       Date:  1989-10-16       Impact factor: 3.575

6.  Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes.

Authors:  A Arimura; A Somogyvári-Vigh; A Miyata; K Mizuno; D H Coy; C Kitada
Journal:  Endocrinology       Date:  1991-11       Impact factor: 4.736

7.  Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors.

Authors:  M I Goth; C E Lyons; B J Canny; M O Thorner
Journal:  Endocrinology       Date:  1992-02       Impact factor: 4.736

8.  Developmental changes of pituitary adenylate cyclase activating polypeptide (PACAP) and its receptor in the rat brain.

Authors:  I Tatsuno; A Somogyvari-Vigh; A Arimura
Journal:  Peptides       Date:  1994-01       Impact factor: 3.750

9.  Effects of pituitary adenylate cyclase-activating polypeptide in the pituitary: activation of two signal transduction pathways in the gonadotrope-derived alpha T3-1 cell line.

Authors:  E Schomerus; A Poch; R Bunting; W T Mason; C A McArdle
Journal:  Endocrinology       Date:  1994-01       Impact factor: 4.736

10.  Pituitary adenylate cyclase activating peptide receptors regulate the growth of non-small cell lung cancer cells.

Authors:  F Zia; M Fagarasan; K Bitar; D H Coy; J R Pisegna; S A Wank; T W Moody
Journal:  Cancer Res       Date:  1995-11-01       Impact factor: 12.701

View more
  6 in total

1.  A structure-function study of PACAP using conformationally restricted analogs: Identification of PAC1 receptor-selective PACAP agonists.

Authors:  Irene Ramos-Álvarez; Samuel A Mantey; Taichi Nakamura; Bernardo Nuche-Berenguer; Paola Moreno; Terry W Moody; Jerome L Maderdrut; David H Coy; Robert T Jensen
Journal:  Peptides       Date:  2015-02-16       Impact factor: 3.750

2.  Differential coupling of the PAC1 SV1 splice variant on human colonic tumors to the activation of intracellular cAMP but not intracellular Ca2+ does not activate tumor proliferation.

Authors:  Patrizia M Germano; Sang V Le; David S Oh; Robert Fan; Sandy Lieu; Alan Siu; Joseph R Pisegna
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

3.  Expression of pituitary adenylate cyclase-activating polypeptide and PACAP type 1 receptor in the rat gastric and colonic myenteric neurons.

Authors:  Marcel Miampamba; Patrizia M Germano; Selin Arli; Helen H Wong; David Scott; Yvette Taché; Joseph R Pisegna
Journal:  Regul Pept       Date:  2002-05-30

4.  PAC1 and PACAP expression, signaling, and effect on the growth of HCT8, human colonic tumor cells.

Authors:  Sang V Le; Dean J Yamaguchi; Craig A McArdle; Ken Tachiki; Joseph R Pisegna; Patrizia Germano
Journal:  Regul Pept       Date:  2002-11-15

5.  PACAP regulation of secretion and proliferation of pure populations of gastric ECL cells.

Authors:  David S Oh; Sandy N Lieu; Dean J Yamaguchi; Ken Tachiki; Nils Lambrecht; Gordon V Ohning; George Sachs; Patrizia M Germano; Joseph R Pisegna
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

6.  PACAP induces signaling and stimulation of 5-hydroxytryptamine release and growth in neuroendocrine tumor cells.

Authors:  Patrizia M Germano; Sandy N Lieu; Janjing Xue; Helen J Cooke; Fievos L Christofi; Yuxin Lu; Joseph R Pisegna
Journal:  J Mol Neurosci       Date:  2009-08-23       Impact factor: 3.444

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.